Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-04-13 @ 7:38 AM
Study NCT ID:
NCT07279532
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-12
First Post:
2025-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuroendocrine Neoplasms (Tumours) | View |
Keywords: